Triple drug iron chelation therapy in thalassemia major; a case report

Ramitha R. Bhat, Harshaprasada Lashkari, Stalin Ramprakash, Diana Pereira

Research output: Contribution to journalArticlepeer-review


Regular packed cell transfusion in patients with thalassemia major leads to iron overload. Chelation therapy is one of the important aspects of thalassemia care as iron overload causes significant cardiac, hepatic, and endocrine dysfunction. We report a case of thalassemia major with severe iron overload causing cardiac and liver dysfunction who benefitted from triple drug chelation therapy. Triple iron chelation therapy in thalassemia major could be suggested in severe iron overload patients.

Original languageEnglish
Pages (from-to)62-64
Number of pages3
JournalIranian Journal of Blood and Cancer
Issue number2
Publication statusPublished - 06-2021

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology


Dive into the research topics of 'Triple drug iron chelation therapy in thalassemia major; a case report'. Together they form a unique fingerprint.

Cite this